cis-Dihydrocarvone is a mint-linked monoterpene ketone most often encountered as a supporting constituent in spearmint, dill, tagetes, and related aromatic profiles. The strongest current evidence is for identity, chirality, occurrence, and use as a flavor or synthesis intermediate, while direct constituent-specific wellness evidence remains thin. For AromaForge it is best described as a chemistry-first archive constituent with modest sensory relevance and clearly labeled research gaps.
Chemical identity and composition
PubChem PUG identifies cis-dihydrocarvone as C10H16O with InChIKey AZOCECCLWFDTAP-BDAKNGLRSA-N. NIST lists CAS 3792-53-8 and a cis p-menth-8-en-2-one naming set. Inside the archive it appears as a minor spearmint constituent around 0.97% in the Oregon COA and as a larger tagetes constituent at 5.0% in the Iranian full-bloom profile already cited in local oil records.
Aroma and practical use
- Use the recorded minty, herbal, warm, woody, herbaceous descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2023 PubMed-indexed biotransformation study described cis-dihydrocarvone as an important flavour and chiral building block and reported selective conversion of S-(+)-carvone to cis-(-)-dihydrocarvone by Ganoderma sessile, reaching 82.7% of the GC-MS profile under optimized conditions.
A 2023 PubMed-indexed biotransformation study described cis-dihydrocarvone as an important flavour and chiral building block and reported selective conversion of S-(+)-carvone to cis-(-)-dihydrocarvone by Ganoderma sessile, reaching 82.7% of the GC-MS profile under optimized conditions.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A 2022 spearmint review states that aromatic molecules including dihydrocarvone are widely used in flavors and fragrances, but it discusses most antimicrobial, antioxidant, insecticidal, anti-inflammatory, and antidiabetic signals at the broader spearmint-molecule group level rather than isolating strong constituent-specific human evidence for cis-dihydrocarvone.
A 2022 spearmint review states that aromatic molecules including dihydrocarvone are widely used in flavors and fragrances, but it discusses most antimicrobial, antioxidant, insecticidal, anti-inflammatory, and antidiabetic signals at the broader spearmint-molecule group level rather than isolating strong constituent-specific human evidence for cis-dihydrocarvone.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedNo strong constituent-specific human safety dossier, IFRA dermal limit, or phototoxicity review for isolated cis-dihydrocarvone was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Most accessible public references treat cis-dihydrocarvone as part of mint, dill, or synthetic chemistry contexts rather than as a standalone toxicology subject.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- No constituent-specific clinical evidence was located for cis-dihydrocarvone.
- Mechanism-level literature for isolated cis-dihydrocarvone remains sparse in the accessible public record.
- Safety coverage is much weaker than identity and occurrence coverage for this constituent.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.